Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy E Richardson

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Neuro-Oncology|March 28, 2026
Expanding the molecular grading criteria in IDH-mutant astrocytomaMichael Christian Virata, Jorge Samanamud, Cheyanne C Slocum, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
Mutant IDH silences GSX2 to reprogram neural progenitor cell fate and promote gliomagenesisYi Xiao, Diana D Shi, Lei Guo, et al.
Nature Metabolism|April 29, 2026
Nitrogen metabolism profiling reveals cell state-specific pyrimidine synthesis pathway choiceMilan R Savani, Bingbing Li, Bailey C Smith, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
Nitrogen metabolism profiling reveals cell state-specific pyrimidine synthesis pathway choiceMilan R Savani, Bailey C Smith, Wen Gu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 31, 2024
Spatial proteomic differences in chronic traumatic encephalopathy, Alzheimer's disease, and primary age-related tauopathy hippocampiTimothy E Richardson, Miranda E Orr, Timothy C Orr, et al.
The Lancet. Oncology|September 4, 2025
The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysisKarenna J Groff, Ruchit V Patel, Yang Feng, et al.
Acta Neuropathologica|May 25, 2026
Neocortical tau burden determines the degree of cognitive impairment in individuals with Braak stage V neurofibrillary degenerationTimothy E Richardson, Jonathan Cherry, Shrishtee Kandoi, et al.
Cancer Cell|August 19, 2022
De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant gliomaDiana D Shi, Milan R Savani, Michael M Levitt, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Gliomas phenocopy an inborn error of metabolism to drive neuronal activity and tumor growthKalil G Abdullah, Kenji Miki, Charles K Edgar, et al.
Journal of Neuropathology and Experimental Neurology|December 28, 2020
Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related TauopathyJamie M Walker, Timothy E Richardson, Kurt Farrell, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Neuro-Oncology|March 28, 2026
Expanding the molecular grading criteria in IDH-mutant astrocytomaMichael Christian Virata, Jorge Samanamud, Cheyanne C Slocum, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
Mutant IDH silences GSX2 to reprogram neural progenitor cell fate and promote gliomagenesisYi Xiao, Diana D Shi, Lei Guo, et al.
Nature Metabolism|April 29, 2026
Nitrogen metabolism profiling reveals cell state-specific pyrimidine synthesis pathway choiceMilan R Savani, Bingbing Li, Bailey C Smith, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
Nitrogen metabolism profiling reveals cell state-specific pyrimidine synthesis pathway choiceMilan R Savani, Bailey C Smith, Wen Gu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 31, 2024
Spatial proteomic differences in chronic traumatic encephalopathy, Alzheimer's disease, and primary age-related tauopathy hippocampiTimothy E Richardson, Miranda E Orr, Timothy C Orr, et al.
The Lancet. Oncology|September 4, 2025
The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysisKarenna J Groff, Ruchit V Patel, Yang Feng, et al.
Acta Neuropathologica|May 25, 2026
Neocortical tau burden determines the degree of cognitive impairment in individuals with Braak stage V neurofibrillary degenerationTimothy E Richardson, Jonathan Cherry, Shrishtee Kandoi, et al.
Cancer Cell|August 19, 2022
De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant gliomaDiana D Shi, Milan R Savani, Michael M Levitt, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Gliomas phenocopy an inborn error of metabolism to drive neuronal activity and tumor growthKalil G Abdullah, Kenji Miki, Charles K Edgar, et al.
Journal of Neuropathology and Experimental Neurology|December 28, 2020
Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related TauopathyJamie M Walker, Timothy E Richardson, Kurt Farrell, et al.
Pageof 11